the ongoing role of everolimus in er-positive mbc
Published 8 years ago • 186 plays • Length 7:02Download video MP4
Download video MP3
Similar videos
-
3:56
role of everolimus in hr metastatic breast cancer
-
9:15
sequencing and role of everolimus in hr-positive breast cancer
-
7:37
next steps for everolimus in er-positive metastatic breast cancer
-
8:33
bolero-2 trial: everolimus in metastatic breast cancer
-
3:43
second-line everolimus in metastatic breast cancer
-
1:03
dr. carey on everolimus in metastatic breast cancer
-
4:29
managing the toxicity of everolimus in breast cancer
-
2:56
everolimus in er-positive breast cancer
-
4:18
adjuvant et /- 1 year of everolimus in patients with high-risk hr-positive, her2-negative bc
-
2:41
everolimus for hr metastatic breast cancer
-
5:32
first-line er-positive metastatic breast cancer treatments
-
1:50
dr. slomovitz discusses a study of everolimus/letrozole or hormonal therapy in endometrial cancer
-
8:28
fulvestrant in the era of cdk4/6 inhibitors for hr mbc
-
2:00
dr. yardley discusses the role of everolimus in breast cancer and the bolero trials
-
1:24
dr. perez discusses the bolero-2 everolimus trial
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
5:01
managing mouth sores from everolimus in breast cancer
-
1:03
azd2014 for treating er metastatic breast cancer – mode of action and trial results
-
0:57
dr. howard burris discusses the mtor inhibitor everolimus for breast cancer